This month, every donation we receive will be matched by a few generous, anonymous donors. Help the next patient receive the options that they need by joining the Cancer Commons family of donors. Your philanthropic support allows us to provide treatment options at no charge. It also allows us to develop an online community knowledge base that will transform cancer care. By learning from every… Read more »
Cancer Commons Connects is our monthly newsletter featuring the latest insights and new developments at Cancer Commons. This month, we feature a new Super Patients post, a new post by our chief scientist Emma Shtivelman on two competing lung cancer drugs, and an interview with our medical director, Kevin Knopf. Click here to view the latest installment of Cancer Commons Connects. If you would like… Read more »
In a new interview, oncologist and Cancer Commons Medical Director Dr. Kevin Knopf gives his perspective on the future of cancer research and treatment, including the role of Cancer Commons. He also discusses the potential benefits of value frameworks, which are tools that take a variety of factors into account in order to aid treatment decisions. Read the full interview here.
Since September 1, 2016, the weekly number of new patients and caregivers seeking help through our ASK Cancer Commons service has increased by about 500%, compared to previous months. This surge occurred organically, with new users finding out about the service solely by word of mouth.
Cancer Commons is featured in a new article about precision medicine published in the scientific journal Nature. Read about our mission and how it fits in with other efforts to empower patients to take a more active role in medical research through data sharing.
Host Kiers Rowley (left) and H8Cancer.org founder and CEO Dr. Simeon Jaggernauth at Tomstock 2016Last weekend Cancer Commons representatives attended Tomstock, an annual benefit concert for the H8 Cancer Foundation. In the spirit of Woodstock, Tomstock was a love-in of sorts, especially for cancer patients and survivors. H8 Cancer has provided generous support to Cancer Commons, enabling us to help more people touched by cancer. We are honored and grateful to have been invited to participate at Tomstock 2016. Above:… Read more »
Cancer Commons founder Marty Tenenbaum’s story of his own battle with melanoma is featured in an article published in The Sydney Morning Herald. The piece outlines how studying “super responders” could help improve cancer treatment for all patients. Read the full article here.
The key to defeating cancer is the ability of doctors, researchers, and patients to share knowledge and insights with one another. In the United States, 1.6 million people are diagnosed with cancer each year. An entire population of patients and families is gaining insights into their cancer every day, but these are not being effectively shared. To end cancer, it is imperative that we create a space for patients to be equal partners in the data sharing conversation.
Dominique Kim and Toni Alejandria show their support at the HackCancer White PartyOn May 21, HackCancer held its 4th Annual White Party in San Francisco. 100% of the net proceeds go to Cancer Commons and will help us get the right treatments to the right patients at the right time. A huge thank you to the organizers and to all who attended! Above: Dominique Kim and Toni Alejandria show their support at the HackCancer White Party. See more… Read more »
51 case reports were submitted to our Exceptional Responders in Oncology competition with Cureus. Now, the winning report has been announced: Unresectable Extraskeletal Myxoid Chondrosarcoma of the Neck: Early Tumor Response to Chemoradiotherapy. Congratulations to Mark Zaki, Pam Laszewski, Natasha Robinette, Husain Saleh, Naweed Raza, Ammar Sukari & Harold Kim! Read more about the competition and the winning case report here.